Attached files
| file | filename |
|---|---|
| EX-21 - EXHIBIT 21 LIST OF SUBS - CHEMBIO DIAGNOSTICS, INC. | exhibit21.htm |
| EX-31.2 - EXHIBIT 31.2 CFO CERT - CHEMBIO DIAGNOSTICS, INC. | ex31_2.htm |
| EX-31.1 - EXHIBIT 31.1 CEO CERT - CHEMBIO DIAGNOSTICS, INC. | ex31_1.htm |
| EX-23.1 - CONSENT OF BDO - CHEMBIO DIAGNOSTICS, INC. | ex23.htm |
| 10-K - FORM 10-K FOR 2016 - CHEMBIO DIAGNOSTICS, INC. | form10_k.htm |
EXHIBIT 32
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K (the "Report") of Chembio Diagnostics, Inc. (the "Company") for the year ended December 31, 2016, each of the undersigned John J. Sperzel, the Chief Executive Officer of the Company, and Richard J. Larkin, the Chief Financial Officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of the undersigneds' knowledge and belief:
(1) This Form 10-K for the year ended December 31, 2016 fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in this Form 10-K for the year ended December 31, 2016 fairly presents, in all material respects, the financial condition and results of operations of Chembio Diagnostics, Inc. for the periods presented therein.
Dated: March 7, 2017 /s/ John J. Sperzel
John J. Sperzel
Chief Executive Officer
Dated: March 7, 2017 /s/ Richard J. Larkin
Richard J. Larkin
Chief Financial Officer